×
About 39,595 results

ALLMedicine™ Type 1 Diabetes Center

Research & Reviews  12,945 results

Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Di...
https://doi.org/10.2337/dc21-0422
Diabetes Care; Jacobsen LM, Vehik K et. al.

Jan 20th, 2022 - The Environmental Determinants of Diabetes in the Young (TEDDY) study is uniquely capable of investigating age-specific differences associated with type 1 diabetes. Because age is a primary driver of heterogeneity in type 1 diabetes, we sought to ...

Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Cate...
https://doi.org/10.2337/db21-0506
Diabetes Chen X, Li Y et. al.

Jan 20th, 2022 - Methazolamide (MTZ), a carbonic anhydrase inhibitor, has been shown to inhibit cardiomyocyte hypertrophy and exert a hypoglycemic effect in patients with type 2 diabetes mellitus and diabetic db/db mice. However, whether MTZ has a cardioprotective...

Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Surve...
https://doi.org/10.2337/dc21-1120
Diabetes Care; Maclean RH, Jacob P et. al.

Jan 20th, 2022 - The Hypoglycemia Fear Survey-II (HFS-II) is a well-validated measure of fear of hypoglycemia in people with type 1 diabetes. The aim of this study was to explore the relationships between hypoglycemia worries, behaviors, and cognitive barriers to ...

Vitamin D and Nerve Conduction In Pediatric Type-1 Diabetes Mellitus.
https://doi.org/10.1016/j.braindev.2022.01.001
Brain & Development; Polat İ, Can Yılmaz G et. al.

Jan 20th, 2022 - The aim of this study is to investigate a possible association between vitamin D deficiency and diabetic peripheral neuropathy in pediatric patients with type 1 diabetes mellitus. Twenty-nine patients with type 1 diabetes mellitus and 19 healthy c...

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic i...
https://doi.org/10.2337/dc21-0969
Diabetes Care; Kamrath C, Rosenbauer J et. al.

Jan 20th, 2022 - The aim of this study was to investigate the incidence of type 1 diabetes in children and adolescents during the coronavirus disease 2019 (COVID-19) pandemic in Germany compared with previous years. Based on data from the multicenter German Diabet...

see more →

Guidelines  15 results

Glucose management for exercise using continuous glucose monitoring (CGM) and intermitt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702152
Pediatric Diabetes; Moser O, Riddell MC et. al.

Oct 14th, 2020 - Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and d...

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438223
Diabetes Research and Clinical Practice; d'Annunzio G, Maffeis C et. al.

Aug 23rd, 2020 - Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated R...
https://doi.org/10.1213/ANE.0000000000004491
Anesthesia and Analgesia; Martin LD, Hoagland MA et. al.

Nov 7th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

see more →

Drugs  378 results see all →

Clinicaltrials.gov  742 results

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES
https://clinicaltrials.gov/ct2/show/NCT03433248

Jan 14th, 2022 - Sodium-glucose linked transporters (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors are relatively novel glucose-lowering drugs for the treatment of T2DM. These agents seem to exert pleiotropic actions 'beyond glucose control'. SG...

Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT03879642

Jan 14th, 2022 - This was a two group randomized controlled study using a wait-list control design. All participating parents had the opportunity to receive 10 video-based telemedicine sessions administered over 13 weeks. Study assessments took place at baseline, ...

Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes
https://clinicaltrials.gov/ct2/show/NCT03973827

Jan 11th, 2022 - An open label, parallel single centre trial of Wharton's Jelly derived allogenic mesenchymal stromal cells repeated treatment to preserve endogenous insulin production in adult patients diagnosed with type 1 diabetes

Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02908087

Jan 11th, 2022 - The main objective of the trial is to study whether daily treatment with liraglutide improves insulin secretion and reduces the requirement of exogenous insulin, and whether liraglutide treatment is tolerable and safe in subjects aged 10-30 years,...

Prevalence of Musculoskeletal Disorders of Upper Limb in Type 1 Diabetes Patients
https://clinicaltrials.gov/ct2/show/NCT05164562

Jan 11th, 2022 - The aim of the study is to describe prevalence of musculoskeletal disorders of upper limb in type 1 diabetes patients.

see more →

News  1,734 results

Stem Cell-Derived Pancreatic Cells May Be Alternative to Islet Transplants
https://www.medscape.com/viewarticle/966794

Jan 20th, 2022 - NEW YORK (Reuters Health) - An ongoing first-in-human trial suggests that pancreatic cells grown from stem cells can be safely implanted into patients with type 1 diabetes, and in some cases, begin producing insulin. "I was surprised by how well t...

Racial Inequities Remain in Offering Advanced Technologies for Patients With Diabetes
https://www.medscape.com/viewarticle/966481

Jan 19th, 2022 - For years, medicine has been plagued with inequities, especially regarding access to care and outcomes. For sure, there have been historical exploitations of some segments of the public, from Nazi experimentation to the infamous Tuskegee syphilis ...

'Artificial Pancreas' Life-Changing in Kids With Type 1 Diabetes
https://www.medscape.com/viewarticle/966813

Jan 19th, 2022 - A semi-automated insulin delivery system improved glycemic control in young children with type 1 diabetes aged 1 to 7 years without increasing hypoglycemia. "Hybrid closed-loop" systems — comprised of an insulin pump, a continuous glucose monitor ...

High-Altitude Exercise May Harm Blood Sugar Control in Type 1 Diabetes
https://www.medscape.com/viewarticle/965667

Jan 4th, 2022 - NEW YORK (Reuters Health) - People with type 1 diabetes mellitus (T1DM) may need to monitor their blood sugar more closely when participating in high-altitude activities such as hiking or skiing, according to results of a small study that found a ...

More Metformin Recalls; Medicare Coverage for CGMs; High-Altitude Woes in T1D
https://www.medpagetoday.com/endocrinology/generalendocrinology/96457

Jan 2nd, 2022 - In the seemingly never-ending saga of metformin recalls, the FDA announced that Viona Pharmaceuticals voluntarily recalled 33 lots of metformin hydrochloride extended-release tablets 750 mg for NDMA impurity. Middle-age and older men with lower to...

see more →

Patient Education  24 results see all →